Castle Biosciences, Inc. logo

Castle Biosciences, Inc.

NASDAQ:CSTL

Overview | Financials
Company Name Castle Biosciences, Inc.
Symbol CSTL
Currency USD
Price 30.36
Market Cap 842,089,248
Dividend Yield 0%
52-week-range 12.07 - 32.53
Industry Diagnostics & Research
Sector Healthcare
CEO Mr. Derek J. Maetzold
Website https://castlebiosciences.com

An error occurred while fetching data.

About Castle Biosciences, Inc.

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary

Related Stocks

Foghorn Therapeutics Inc. logo

Foghorn Therapeutics Inc.

FHTX

9.56 USD

Sangamo Therapeutics, Inc. logo

Sangamo Therapeutics, Inc.

SGMO

0.837 USD

The Pennant Group, Inc. logo

The Pennant Group, Inc.

PNTG

34.99 USD

Bioventus Inc. logo

Bioventus Inc.

BVS

11.69 USD

Surmodics, Inc. logo

Surmodics, Inc.

SRDX

39.3 USD

Financials

Numbers are in millions USD

Numbers are in millions USD